SCHEMBL2863237

SCHEMBL2863237

O=C(NCc1cc2c(-c3cccc(F)c3)n[nH]c2cc1F)c1cccc(F)c1

nearest known ligand 0.52

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 1/20 0.52
MAP2K4 P45985 1/20 0.50
TTK P33981 5/20 0.48
MAPK1 P28482 7/20 0.48
MAPK3 P27361 4/20 0.47
DGAT2 Q96PD7 1/20 0.45
CHRM3 P20309 1/20 0.45
NTRK1 P04629 2/20 0.44
ROCK2 O75116 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13635746 0.93 CSNK1D (0.49) CSNK1DMAP2K4TTKMAPK1MAPK3
SCHEMBL2867437 0.91 CSNK1D (0.47) CSNK1DMAP2K4MAPK1MAPK3DGAT2
SCHEMBL2862635 0.91 DGAT2 (0.56) CSNK1DTTKDGAT2NTRK1ROCK2
SCHEMBL2870355 0.91 MAPK1 (0.50) CSNK1DMAP2K4TTKMAPK1MAPK3
SCHEMBL2863001 0.87 NTRK1 (0.56) CSNK1DMAP2K4TTKMAPK1MAPK3
SCHEMBL13198273 0.84 DGAT2 (0.50) CSNK1DTTKMAPK1DGAT2NTRK1
SCHEMBL2872610 0.82 DGAT2 (0.56) CSNK1DTTKMAPK1DGAT2NTRK1
SCHEMBL2870798 0.79 NTRK1 (0.52) CSNK1DMAPK1DGAT2NTRK1ROCK2
SCHEMBL2866831 0.79 CSNK1D (0.51) CSNK1DDGAT2ROCK2HPGD
SCHEMBL2870225 0.79 NTRK1 (0.50) CSNK1DTTKMAPK1DGAT2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 CSNK1D 134/4885MAP2K4 61/4885TTK 1201/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 CSNK1D 90/4885MAP2K4 53/4885TTK 1066/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 CSNK1D 134/4885MAP2K4 61/4885TTK 1201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.